Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 296860, 11 pages
http://dx.doi.org/10.1155/2014/296860
Review Article

A Review of In Vitro and In Vivo Studies on the Efficacy of Herbal Medicines for Primary Dysmenorrhea

Department of Korean Medicine Obstetrics & Gynecology, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of Korea

Received 9 May 2014; Revised 11 October 2014; Accepted 13 October 2014; Published 5 November 2014

Academic Editor: Yuping Tang

Copyright © 2014 Kyoung-Sun Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. Lichten and J. Bombard, “Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation,” The Journal of Reproductive Medicine, vol. 32, no. 1, pp. 37–41, 1987. View at Google Scholar · View at Scopus
  2. M. Y. Dawood, “Primary dysmenorrhea: advances in pathogenesis and management,” Obstetrics & Gynecology, vol. 108, no. 2, pp. 428–441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Durain, “Primary dysmenorrhea: assessment and management update,” Journal of Midwifery and Women's Health, vol. 49, no. 6, pp. 520–527, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Proctor and C. Farquhar, “Diagnosis and management of dysmenorrhoea,” British Medical Journal, vol. 332, no. 7550, pp. 1134–1138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Marjoribanks, M. Proctor, C. Farquhar, and R. S. Derks, “Nonsteroidal anti-inflammatory drugs for dysmenorrhoea,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Y. Dawood, “Dysmenorrhea,” The Journal of Reproductive Medicine, vol. 30, no. 3, pp. 154–167, 1985. View at Google Scholar · View at Scopus
  7. D. Taylor, C. Miaskowski, and J. Kohn, “A randomized clinical trial of the effectiveness of an acupressure device (relief brief) for managing symptoms of dysmenorrhea,” The Journal of Alternative and Complementary Medicine, vol. 8, no. 3, pp. 357–370, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. A. G. Rodríguez, R. Williams, L. E. Derby, A. D. Dean, and H. Jick, “Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors,” Archives of Internal Medicine, vol. 154, no. 3, pp. 311–316, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Gutthann, L. A. G. Rodríguez, D. S. Raiford, A. D. Oliart, and J. R. Romeu, “Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure,” Archives of Internal Medicine, vol. 156, no. 21, pp. 2433–2439, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Creatsas, E. Deligeoroglou, A. Zachari et al., “Prostaglandins: PGF2α, PGE2, 6-keto-PGF1α and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 36, no. 3, pp. 292–298, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. S. L. Hendrix and N. J. Alexander, “Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive,” Contraception, vol. 66, no. 6, pp. 393–399, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Vercellini, G. Frontino, O. De Giorgi, G. Pietropaolo, R. Pasin, and P. G. Crosignani, “Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen,” Fertility and Sterility, vol. 80, no. 3, pp. 560–563, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Proctor, P. M. Latthe, C. M. Farquhar, K. S. Khan, and N. P. Johnson, “Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD001896, 2005. View at Google Scholar · View at Scopus
  14. C.-S. Hsu, J.-K. Yang, and L.-L. Yang, “Effect of “Dang-Qui-Shao-Yao-San” a Chinese medicinal prescription for dysmenorrhea on uterus contractility in vitro,” Phytomedicine, vol. 13, no. 1-2, pp. 94–100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Hasani-Ranjbar, B. Larijani, and M. Abdollah, “A systematic review of iranian medicinal plants useful in diabetes mellitus,” Archives of Medical Science, vol. 4, no. 3, pp. 285–292, 2008. View at Google Scholar · View at Scopus
  16. B. Ji, L. F. Zhang, J. Zhu et al., “On building the dysmenorrheal model and assessment methods,” Chinese Pharmacological Bulletin, vol. 24, pp. 711–714, 2008. View at Google Scholar
  17. E. Bytautiene, Y. P. Vedernikov, G. R. Saade, R. Romero, and R. E. Garfield, “Effect of histamine on phasic and tonic contractions of isolated uterine tissue from pregnant women,” American Journal of Obstetrics and Gynecology, vol. 188, no. 3, pp. 774–778, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Liu, J.-A. Duan, Y.-Q. Hua, Y.-P. Tang, X. Yao, and S.-L. Su, “Effects of Xiang-Fu-Si-Wu Decoction and its main components for dysmenorrhea on uterus contraction,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 591–597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Nissenson, G. Flouret, and O. Hechter, “Opposing effects of estradiol and progesterone on oxytocin receptors in rabbit uterus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 4, pp. 2044–2048, 1978. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Y. Dawood, “Dysmenorrhea,” Current Obstetrics & Gynaecology, vol. 3, no. 4, pp. 219–224, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Lumsden, R. W. Kelly, and D. T. Baird, “Primary dysmenorrhoea: The importance of both prostaglandins E2 and F2α,” British Journal of Obstetrics and Gynaecology, vol. 90, no. 12, pp. 1135–1140, 1983. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Powell, W. Y. Chan, P. Alvin, and I. F. Litt, “Menstrual-PGF2α, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea,” Prostaglandins, vol. 29, no. 2, pp. 273–289, 1985. View at Google Scholar · View at Scopus
  23. A. S. Coco, “Primary dysmenorrhea,” American Family Physician, vol. 60, no. 2, pp. 489–496, 1999. View at Google Scholar · View at Scopus
  24. A. Imai, S. Horibe, S. Fuseya, K. Iida, H. Takagi, and T. Tamaya, “Possible evidence that the herbal medicine shakuyaku-kanzo-to decreases prostaglandin levels through suppressing arachidonate turnover in endometrium,” Journal of Medicine, vol. 26, no. 3-4, pp. 163–174, 1995. View at Google Scholar · View at Scopus
  25. Y. Q. Hua, S. L. Su, J. A. Duan, Q. J. Wang, Y. Lu, and L. Chen, “Danggui-Shaoyao-San, a traditional Chinese prescription, suppresses PGF2α production in endometrial epithelial cells by inhibiting COX-2 expression and activity,” Phytomedicine, vol. 15, no. 12, pp. 1046–1052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. D. K. Rowlands, Y. G. Cui, S. C. So, L. L. Tsang, Y. W. Chung, and H. C. Chan, “Bak Foong Pills induce an analgesic effect by inhibiting nociception via the somatostatin pathway in mice,” Cell Biology International, vol. 36, no. 1, pp. 63–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Su, Y. Hua, Y. Wang et al., “Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 649–656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. D. L. DeWitt, “Prostaglandin endoperoxide synthase: regulation of enzyme expression,” Biochimica et Biophysica Acta, vol. 1083, no. 2, pp. 121–134, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. W. L. Smith, “Prostanoid biosynthesis and mechanisms of action,” American Journal of Physiology: Renal Fluid and Electrolyte Physiology, vol. 263, no. 2, pp. F181–F191, 1992. View at Google Scholar · View at Scopus
  30. T. A. Samad, A. Sapirstein, and C. J. Woolf, “Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets,” Trends in Molecular Medicine, vol. 8, no. 8, pp. 390–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Asselin, P. Drolet, and M. A. Fortier, “Cellular mechanisms involved during oxytocin-induced prostaglandin F2α production in endometrial epithelial cells in vitro: role of cyclooxygenase-2,” Endocrinology, vol. 138, no. 11, pp. 4798–4805, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. K. J. Sales and H. N. Jabbour, “Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium,” Reproduction, vol. 126, no. 5, pp. 559–567, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. D. R. Halbert and L. M. Demers, “A clinical trial of indomethacin and ibuprofen in dysmenorrhea,” The Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 21, no. 4, pp. 219–222, 1978. View at Google Scholar · View at Scopus
  34. Z. Rosenwaks, G. S. Jones, M. R. Henzl, N. H. Dubin, R. B. Ghodgaonkar, and S. Hoffman, “Naproxen sodium, aspirin, and placebo in primary dysmenorrhea. Reduction of pain and blood levels of prostaglandin F2α metabolite,” American Journal of Obstetrics and Gynecology, vol. 140, no. 5, pp. 592–598, 1981. View at Google Scholar · View at Scopus
  35. Y. Shi, D. Wu, Z. Sun et al., “Analgesic and uterine relaxant effects of isoliquiritigenin, a flavone from Glycyrrhiza glabra,” Phytotherapy Research, vol. 26, no. 9, pp. 1410–1417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Chen, Y. Cao, Y. Xie et al., “Traditional Chinese medicine for the treatment of primary dysmenorrhea: how do Yuanhu painkillers effectively treat dysmenorrhea?” Phytomedicine, vol. 20, no. 12, pp. 1095–1104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. N. V. Guliaeva, N. L. Luzina, I. P. Levshina, and G. N. Kryzhanovskiǐ, “The inhibition stage of lipid peroxidation during stress,” Bulletin of Experimental Biology and Medicine, vol. 106, no. 12, pp. 660–663, 1988. View at Google Scholar · View at Scopus
  38. N. Ilhan, I. Halifeoglu, and H. I. Ozercan, “Tissue malondialdehyde and adenosine triphosphatase level after experimental liver ischaemia-reperfusion damage,” Cell Biochemistry and Function, vol. 19, no. 3, pp. 207–212, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-L. Yeh, H.-H. Chen, E. C. So, and C.-F. Liu, “A study of serum malondialdehyde and interleukin-6 levels in young women with dysmenorrhea in Taiwan,” Life Sciences, vol. 75, no. 6, pp. 669–673, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Dikensoy, O. Balat, S. Pençe, A. Balat, M. Çekmen, and M. Yurekli, “Malondialdehyde, nitric oxide and adrenomedullin levels in patients with primary dysmenorrhea,” Journal of Obstetrics and Gynaecology Research, vol. 34, no. 6, pp. 1049–1053, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Suzer, E. Coskun, S. Demir, and K. Tahta, “Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine,” Research in Experimental Medicine, vol. 199, no. 4, pp. 223–229, 2000. View at Google Scholar · View at Scopus
  42. N. Seyhan and A. G. Canseven, “In vivo effects of ELF MFs on collagen synthesis, free radical processes, natural antioxidant system, respiratory burst system, immune system activities, and electrolytes in the skin, plasma, spleen, lung, kidney, and brain tissues,” Electromagnetic Biology and Medicine, vol. 25, no. 4, pp. 291–305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Nogawa, C. Forster, F. Zhang, M. Nagayama, M. E. Ross, and C. Iadecola, “Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10966–10971, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Gu, M. Kaul, B. Yan et al., “S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death,” Science, vol. 297, no. 5584, pp. 1186–1190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. M.-F. Sun, H.-C. Huang, S.-C. Lin, L.-P. Chang, and C.-F. Liu, “Evaluation of nitric oxide and homocysteine levels in primary dysmenorrheal women in Taiwan,” Life Sciences, vol. 76, no. 17, pp. 2005–2009, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  47. H.-Y. Yun, V. L. Dawson, and T. M. Dawson, “Neurobiology of nitric oxide,” Critical Reviews in Neurobiology, vol. 10, no. 3-4, pp. 291–316, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. C.-H. Liao, C.-T. Ho, and J.-K. Lin, “Effects of garcinol on free radical generation and NO production in embryonic rat cortical neurons and astrocytes,” Biochemical and Biophysical Research Communications, vol. 329, no. 4, pp. 1306–1314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. Y.-J. Surh, K.-S. Chun, H.-H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 480-481, pp. 243–268, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Ma, S. Su, J. Duan et al., “Evaluation of the analgesic activities of the crude aqueous extract and fractions of Shao Fu Zhu Yu decoction,” Pharmaceutical Biology, vol. 49, no. 2, pp. 137–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. I.-S. Selmer, M. Schindler, J. P. Allen, P. P. A. Humphrey, and P. C. Emson, “Advances in understanding neuronal somatostatin receptors,” Regulatory Peptides, vol. 90, no. 1–3, pp. 1–18, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. S. A. Abd El-Aleem, B. M. Morales-Aza, D. S. McQueen, and L. F. Donaldson, “Inflammation alters somatostatin mRNA expression in sensory neurons in the rat,” European Journal of Neuroscience, vol. 21, no. 1, pp. 135–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Ruttner, T. Ivanics, D. W. Slaaf, R. S. Reneman, A. Toth, and L. Ligeti, “In vivo monitoring of intracellular free calcium changes during uterine activation by prostaglandin f2α and oxytocin,” Journal of the Society for Gynecologic Investigation, vol. 9, no. 5, pp. 294–298, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Wray, K. Jones, S. Kupittayanant et al., “Calcium signaling and uterine contractility,” Journal of the Society for Gynecologic Investigation, vol. 10, no. 5, pp. 252–264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Fenakel and S. Lurie, “The use of calcium channel blockers in obstetrics and gynecology; a review,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 37, no. 3, pp. 199–203, 1990. View at Publisher · View at Google Scholar · View at Scopus
  56. S.-M. Hsia, Y.-H. Kuo, W. Chiang, and P. S. Wang, “Effects of adlay hull extracts on uterine contraction and Ca2+ mobilization in the rat,” American Journal of Physiology: Endocrinology and Metabolism, vol. 295, no. 3, pp. E719–E726, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Liu, J. Duan, P. Wang et al., “Biomarkers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine,” Molecular BioSystems, vol. 9, no. 1, pp. 77–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Liu, J.-A. Duan, J.-M. Guo et al., “Plasma metabolic profiling of normal and dysmenorrhea syndrome rats and the effects of Xiang-Fu-Si-Wu Decoction intervention,” Pharmaceutical Biology, vol. 52, no. 5, pp. 603–613, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. A. C. Pessini, A. Kanashiro, D. D. C. Malvar et al., “Inflammatory mediators involved in the nociceptive and oedematogenic responses induced by Tityus serrulatus scorpion venom injected into rat paws,” Toxicon, vol. 52, no. 7, pp. 729–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. H.-Y. Ma, J.-P. Kou, J.-R. Wang, and B.-Y. Yu, “Evaluation of the anti-inflammatory and analgesic activities of Liu-Shen-Wan and its individual fractions,” Journal of Ethnopharmacology, vol. 112, no. 1, pp. 108–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. C.-S. Hsu, J.-K. Yang, and L.-L. Yang, “Effect of a dysmenorrhea Chinese medicinal prescription on uterus contractility in vitro,” Phytotherapy Research, vol. 17, no. 7, pp. 778–783, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Du, B. Bai, X. Kuang et al., “Ligustilide inhibits spontaneous and agonists- or K+ depolarization-induced contraction of rat uterus,” Journal of Ethnopharmacology, vol. 108, no. 1, pp. 54–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Perez-Hernandez, H. Ponce-Monter, J. A. Medina, and P. Joseph-Nathan, “Spasmolytic effect of constituents from Lepechinia caulescens on rat uterus,” Journal of Ethnopharmacology, vol. 115, no. 1, pp. 30–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. D. K. Rowlands, Y. G. Cui, H. Y. Wong, Y. L. Gou, and H. C. Chan, “Traditional Chinese medicine Bak Foong Pills alters uterine quiescence—possible role in alleviation of dysmenorrhoeal symptoms,” Cell Biology International, vol. 33, no. 12, pp. 1207–1211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Su, Y. Hua, J.-A. Duan, W. Zhou, E. Shang, and Y. Tang, “Inhibitory effects of active fraction and its main components of Shaofu Zhuyu decoction on uterus contraction,” The American Journal of Chinese Medicine, vol. 38, no. 4, pp. 777–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. H.-C. Shih and L.-L. Yang, “Relaxant effect induced by wogonin from Scutellaria baicalensis on rat isolated uterine smooth muscle,” Pharmaceutical Biology, vol. 50, no. 6, pp. 760–765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Jia, Y. Li, Z. Lei et al., “Relaxative effect of core licorice aqueous extract on mouse isolated uterine horns,” Pharmaceutical Biology, vol. 51, no. 6, pp. 744–748, 2013. View at Publisher · View at Google Scholar · View at Scopus